Skip to content

Second Ovulation Induction

Outcomes From Secondary Ovulation Induction Following Failed Oocyte Pick-up IVF Cycles

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06502665
Enrollment
87
Registered
2024-07-16
Start date
2024-07-04
Completion date
2025-05-20
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, IVF

Brief summary

Studies reported various risk factors for inadequate ovulation induction such as body mass index, low ovarian reserve, low baseline FSH and LH, and previous use of contraception or agonist. The flexibility to use human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone agonist (GnRHa) in ovulation induction for antagonist protocol or progestin primed ovarian stimulation (PPOS) is an advantage helping fertility doctors to decrease the risk of ovarian hyperstimulation syndrome. However, luteinizing hormone (LH) levels \<15UI/L and progesterone ≤11.13nmol/L eight to twelve hours post GnRHa trigger were highly correlated to failed oocyte pickup (FOP). Rescue hCG have been found to increase favorable outcomes in patients with FOP. The presence of false FOP could be due pharmaceutical reasons and human error. Genuine FOP could be due to intrinsic ovarian pathology. The FOP is defined as the absence of oocytes after ovarian stimulation and follicular aspiration. It is an uncomfortable situation for the patient and medical team to deal with due to the apparent expectations of favorable results. Ovulation induction could be via GnRHa, HCG, or both in antagonist protocol and PPOS protocol. Long or short agonist protocol could be triggered only via HCG.

Interventions

OTHERWomen having had second ovulation induction after failed oocyte pick-up

IVF success is defined by the number of retrieved oocytes. Identifying women at risk of failed oocyte pick-up at the first oocyte pick-up and optimizing their ovulation induction could enhance outcomes

Sponsors

Clinique Ovo
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Participants with no oocytes retrieved in the first ovum pick-up

Exclusion criteria

* Error in trigger medication or timing by the patient/ medical team * Major absence of information (primary objective, trigger medication, time interval of trigger and ovum pick-up

Design outcomes

Primary

MeasureTime frameDescription
Oocyte pick-up at retrieval36 hours after ovulation triggeringNumber of retrieved oocytes after second ovulation induction in patients with FOP

Secondary

MeasureTime frameDescription
Timing of ovulation triggering24 to 36 hours after ovulation triggeringTime interval outcomes between trigger and ovum pickup

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026